Singapore markets open in 2 hours 27 minutes

Inovio Pharmaceuticals, Inc. (INO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
8.40-0.10 (-1.18%)
At close: 4:00PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 51.76B
Enterprise value 31.27B
Trailing P/E N/A
Forward P/E 1-15.27
PEG Ratio (5 yr expected) 1-0.12
Price/sales (ttm)272.49
Price/book (mrq)3.02
Enterprise value/revenue 3197.40
Enterprise value/EBITDA 7-8.61

Trading information

Stock price history

Beta (5Y monthly) 0.65
52-week change 3-59.40%
S&P500 52-week change 333.41%
52-week high 322.13
52-week low 35.81
50-day moving average 38.63
200-day moving average 39.31

Share statistics

Avg vol (3-month) 35.3M
Avg vol (10-day) 32.71M
Shares outstanding 5209.4M
Implied shares outstanding 6N/A
Float 206M
% held by insiders 11.66%
% held by institutions 136.54%
Shares short (14 Jul 2021) 445.5M
Short ratio (14 Jul 2021) 410.45
Short % of float (14 Jul 2021) 422.09%
Short % of shares outstanding (14 Jul 2021) 421.73%
Shares short (prior month 14 Jun 2021) 446.74M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:4
Last split date 305 Jun 2014

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Mar 2021


Profit margin 0.00%
Operating margin (ttm)-2,345.51%

Management effectiveness

Return on assets (ttm)-19.04%
Return on equity (ttm)-49.06%

Income statement

Revenue (ttm)6.46M
Revenue per share (ttm)0.04
Quarterly revenue growth (yoy)-72.00%
Gross profit (ttm)-86.83M
EBITDA -147.97M
Net income avi to common (ttm)-188.27M
Diluted EPS (ttm)-1.08
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)518.6M
Total cash per share (mrq)2.48
Total debt (mrq)33.9M
Total debt/equity (mrq)5.83
Current ratio (mrq)14.17
Book value per share (mrq)2.78

Cash flow statement

Operating cash flow (ttm)-205.39M
Levered free cash flow (ttm)-130.03M